Trusted by the judiciary, government lawyers, prosecutors, and many leading counsel. Click here to request a subscription.
|
or click here to request site subscription to search and view all judgments |
Court of Appeal upholds the High Court's decision that the patent for a widely-used anti-coagulant medicine is invalid, thus invalidating the associated Supplementary Protection Certificate; but the court grants an injunction restraining a generic pharmaceutical company from launching a competing product until the appeal is determined, recognising the potential for irreparable harm to the patent holder's market position and exclusivity rights.
Patent invalidity - Supplementary Protection Certificate (SPC) - Anti-coagulant medicine - Generic pharmaceutical entry - Injunction pending appeal - Irreparable harm - Market exclusivity - Intellectual property rights - High Court judgment - Court of Appeal decision - Health Products Regulatory Authority (HPRA) - Interchangeable medicinal products - Price spiral - Adequacy of damages - Status quo ante - Expedited proceedings
Note: This is intended to be a fair and accurate report of a decision made public by a court of law. Any errors should be notified to the editor and will be dealt with accordingly.
The only subject matter index for all Irish judgments over the past thirteen years. Click here to request a subscription.
Register Now